Editorial
 
Summary of the primer on tumor immunology and the biological therapy of cancer
Yufeng Li, Shujuan Liu, Kim Margolin, Patrick Hwu
Journal of Translational Medicine 2009, 7:11 (28 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation
Philippe Veron, Sylvie Boutin, Samia Martin, Laurence Chaperot, Joel Plumas, Jean Davoust, Carole Masurier
Journal of Translational Medicine 2009, 7:10 (27 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Commentary
Perfused human organs versus Mary Shelley's Frankenstein
Lawrence Leung
Journal of Translational Medicine 2009, 7:9 (23 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors
Jit Kong Cheong, Lakshman Gunaratnam, Zhi Jiang Zang, Christopher M Yang, Xiaoming Sun, Susan L Nasr, Khe Guan Sim, Bee Keow Peh, Suhaimi Bin Abdul Rashid, Joseph V Bonventre, Manuel Salto-Tellez, Stephen I Hsu
Journal of Translational Medicine 2009, 7:8 (20 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Methodology
High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia
Gero Hütter, Anne Letsch, Daniel Nowak, Julia Poland, Pranav Sinha, Eckhard Thiel, Wolf-K Hofmann
Journal of Translational Medicine 2009, 7:7 (15 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
Stem cells from umbilical cord blood do have myogenic potential, with and without differentiation induction in vitro
Tatiana Jazedje, Mariane Secco, Natássia M Vieira, Eder Zucconi, Thomaz R Gollop, Mariz Vainzof, Mayana Zatz
Journal of Translational Medicine 2009, 7:6 (14 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target
Adriana Albini, Claudio Brigati, Agostina Ventura, Girieca Lorusso, Marta Pinter, Monica Morini, Alessandra Mancino, Antonio Sica, Douglas M Noonan
Journal of Translational Medicine 2009, 7:5 (14 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
Can urinary exosomes act as treatment response markers in prostate cancer?
Paul J Mitchell, Joanne Welton, John Staffurth, Jacquelyn Court, Malcolm D Mason, Zsuzsanna Tabi, Aled Clayton
Journal of Translational Medicine 2009, 7:4 (12 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
Semi-allogeneic vaccines and tumor-induced immune tolerance
Jin Yu, Mark S Kindy, Sebastiano Gattoni-Celli
Journal of Translational Medicine 2009, 7:3 (8 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma
Howard L Kaufman, Bret Taback, William Sherman, Dae Won Kim, William H Shingler, Dorota Moroziewicz, Gail DeRaffele, Josephine Mitcham, Miles W Carroll, Richard Harrop, Stuart Naylor, Seunghee Kim-Schulze
Journal of Translational Medicine 2009, 7:2 (7 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients
Jun-ichi Kobayashi, Toshihiko Torigoe, Yoshihiko Hirohashi, Satomi Idenoue, Akihiro Miyazaki, Akira Yamaguchi, Hiroyoshi Hiratsuka, Noriyuki Sato
Journal of Translational Medicine 2009, 7:1 (6 January 2009)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
|
